Integer Announces Commitments to Reprice and Extend Maturity of its Revolving Credit Facility and Term Loan A; Launches Term Loan B Repricing
PLANO, Texas, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced that it has received commitments to extend the maturity for its existing Revolving Credit Facility and Term Loan A to October 2022, and reduce the respective pricing by 25 basis points. The Company also announced that it launched a process to reprice its Term Loan B (TLB). A copy of the lender presentation prepared by Integer in connection with the TLB repricing process has been posted at investor.integer.net.
The terms, timing and ultimate consummation of any such repricing are subject to market and other conditions.
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular, portable medical and orthopedics markets. The Company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. The Company’s brands include GreatbatchTM Medical, Lake Region MedicalTM and ElectrochemTM. Additional information is available at www.integer.net.
Tony BorowiczSVP, Strategy, Corporate Development & Investor Relations 716.759.5809 email@example.com